- Home
- MBLY vs BMRN Comparison
MBLY vs BMRN Comparison
Compare MBLY & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBLY
- BMRN
- Stock Information
- Founded
- MBLY 1999
- BMRN 1996
- Country
- MBLY Israel
- BMRN United States
- Employees
- MBLY N/A
- BMRN N/A
- Industry
- MBLY Computer Software: Prepackaged Software
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- MBLY Technology
- BMRN Health Care
- Exchange
- MBLY Nasdaq
- BMRN Nasdaq
- Market Cap
- MBLY 11.2B
- BMRN 11.1B
- IPO Year
- MBLY 2022
- BMRN 1999
- Fundamental
- Price
- MBLY $14.25
- BMRN $54.37
- Analyst Decision
- MBLY Buy
- BMRN Buy
- Analyst Count
- MBLY 17
- BMRN 24
- Target Price
- MBLY $20.06
- BMRN $91.70
- AVG Volume (30 Days)
- MBLY 4.2M
- BMRN 1.8M
- Earning Date
- MBLY 10-30-2025
- BMRN 10-28-2025
- Dividend Yield
- MBLY N/A
- BMRN N/A
- EPS Growth
- MBLY N/A
- BMRN 154.69
- EPS
- MBLY N/A
- BMRN 3.40
- Revenue
- MBLY $1,920,000,000.00
- BMRN $3,063,608,000.00
- Revenue This Year
- MBLY $13.66
- BMRN $13.32
- Revenue Next Year
- MBLY $9.95
- BMRN $9.37
- P/E Ratio
- MBLY N/A
- BMRN $16.00
- Revenue Growth
- MBLY 4.07
- BMRN 18.36
- 52 Week Low
- MBLY $11.12
- BMRN $52.93
- 52 Week High
- MBLY $22.51
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- MBLY 50.12
- BMRN 40.90
- Support Level
- MBLY $13.66
- BMRN $52.94
- Resistance Level
- MBLY $14.26
- BMRN $56.07
- Average True Range (ATR)
- MBLY 0.52
- BMRN 1.56
- MACD
- MBLY 0.02
- BMRN -0.38
- Stochastic Oscillator
- MBLY 49.07
- BMRN 20.88
About MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Others. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.